From: Clinical outcomes of submassive pulmonary embolism thrombolysis—an Indian experience
Control group | Thrombolysis group | |||||
---|---|---|---|---|---|---|
N (%) | p value | N (%) | p value | |||
Dilated RA/RV | Pre vs. post | 20 (45.5%) vs. 20 (45.5%) (n = 44) | 1.000 | 26 (61.9%) vs. 11 (26.2%) (n = 42) | 0.001* | |
Pre vs. day 30 | 14 (40.0%) vs. 13 (37.1%) (n = 35) | 1.000 | 21 (58.3%) vs. 6 (16.7%) (n = 36) | 0.001* | ||
Post vs. day 30 | 14 (40.0%) vs. 13 (37.1%) (n = 35) | 1.000 | 10 (27.8%) vs. 6 (16.7%) (n = 36) | 0.344 | ||
RV systolic dysfunction | Pre vs. post | 24 (54.5%) vs. 21 (47.7%) (n = 44) | 0.629 | 22 (52.4%) vs. 8 (19.0%) (n = 42) | 0.004* | |
Pre vs. day 30 | 19 (37.1%) vs. 11 (31.4%) (n = 35) | 0.096 | 19 (52.8%) vs. 3 (8.3%) (n = 36) | 0.0001* | ||
Post vs. day 30 | 19 (54.3%) vs. 11 (31.4%) (n = 35) | 0.057 | 5 (13.9%) vs. 3 (8.3%) (n = 36) | 0.727 | ||
Tricuspid regurgitation | Pre | Mild | 5 (11.4%) | 0.064 | 7 (16.7%) | 0.0001* |
Moderate | 29 (65.9%) | 22 (52.4%) | ||||
Sever | 10 (22.7%) | 13 (31.0%) | ||||
Post | Mild | 15 (34.1%) | 32 (76.2%) | |||
Moderate | 22 (50.0%) | 10 (23.8%) | ||||
Sever | 7 (15.9%) | 0 (0.0%) | ||||
Pre | Mild | 4 (11.4%) | 0.011* | 6 (16.7%) | 0.0001* | |
Moderate | 22 (62.9%) | 20 (55.6%) | ||||
Sever | 9 (25.7%) | 10 (27.8%) | ||||
Day 30 | Mild | 15 (42.9%) | 23 (63.9%) | |||
Moderate | 15 (42.9%) | 13 (36.1%) | ||||
Sever | 5 (14.3%) | 0 (0.0%) | ||||
Post | Mild | 12 (34.3%) | 0.678 | 26 (72.2%) | 0.678 | |
Moderate | 18 (51.4%) | 10 (27.8%) | ||||
Sever | 5 (14.3%) | 0 (0.0%) | ||||
Day 30 | Mild | 15 (42.9%) | 23 (63.9%) | |||
Moderate | 15 (42.9%) | 13 (36.1%) | ||||
Sever | 5 (14.3%) | 0 (0.0%) |